Clinical Trial Update: Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ranibizumab with or without laser versus laser alone for Branch Retinal Vein Occlusion, assessing efficacy and safety; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Branch Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2016-11-10